At AbbVie, R&D centers around the patient, from understanding disease biology to treatment delivery, clinical trials, and beyond. We combine our experience pioneering scientific breakthroughs, the best ideas in science, and advanced technologies to develop the next generation of medicines.
Since our launch in 2013, we have invested ~$50 billion in R&D, enabling us to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.
We focus our R&D efforts on a core set of therapeutic areas — where we have proven expertise, and see greater potential to improve how diseases are managed. These include oncology, immunology, neuroscience, eye care, virology, and our Allergan Aesthetics portfolio.